Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-18
Biography and Research Information
OverviewAI-generated summary
Prabhat Singh Malik's research focuses on lung cancer, particularly non-small cell lung cancer, and its management. His work has investigated various aspects of lung cancer, including assessment of brain metastasis at diagnosis in a prospective observational study from North India. He has also explored the potential of specific microRNAs (miR-375-3p, miR-197-3p, and miR-15a-5p) as biomarkers in lung cancer and their clinical relevance. Additionally, Malik has contributed to research on neoadjuvant Osimertinib for resectable *EGFR*-mutated non-small cell lung cancer and the development of a National Cancer Database for Cost and Quality of Life in India.
Beyond lung cancer, his research interests extend to other oncological areas, such as pazopanib-based oral metronomic therapy for platinum-resistant/refractory epithelial ovarian cancer. He has also examined the impact of comorbidities like diabetes and hypertension on COVID-19 infection severity and mortality in India. His publications demonstrate a commitment to clinical trials, including a double-blind randomized controlled trial on topical diclofenac for preventing capecitabine-associated hand-foot syndrome.
With an h-index of 22 and over 222 publications, Malik is recognized as a highly cited researcher. His work spans clinical studies, biomarker analysis, and the development of healthcare databases, with a significant focus on cancer-related research and patient outcomes.
Metrics
- h-index: 22
- Publications: 222
- Citations: 1,909
Selected Publications
-
Psychological distress and quality of life during chemotherapy for non-small cell lung cancer: prospective observational study (2025)
-
All That Glitters Is Not Gold: Crystal-Storing Histiocytosis Presenting as a Lung Mass (2025)
-
Characteristics of long term survivors of multiple myeloma after autologous stem cell transplantation: a retrospective analysis from a tertiary care centre in India (2025)
-
Combination chemotherapy with gefitinib as first-line treatment in EGFR-mutated metastatic non-small cell lung cancer: A retrospective Indian experience (2025)
-
Pattern of care in locally advanced non-small cell lung cancer: A tertiary care experience from India (2025)
-
A profile of lung cancer in the young population with a highlight on the Indian perspective (2025)
-
Recent Advances in the Management of EGFR-Mutated Advanced Non-Small Cell Lung Cancer—A Narrative Review (2025)
-
ALK rearranged malignant mesenchymal neoplasms of thorax: therapeutically targetable ‘ALKomas’ beyond the spectrum of non-small cell lung carcinomas and thoracic inflammatory myofibroblastic tumors (2025)
-
Clinical spectrum of lung cancer across hospitals under the National Cancer Registry Programme in India: Challenges and opportunities (2025)
-
Recent Advances in the Management of EGFR Mutated Advanced Non-Small Cell Lung Cancer-A Narrative Review (2025)
-
Neoadjuvant Osimertinib for Resectable <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer (2025)
-
Delphi Survey on Measurable Residual Disease in Multiple Myeloma: Prevailing Practices and the Way Forward in India (2025)
-
Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature (2025)
-
Safety of nivolumab in treating Indian patients with non-small-cell lung carcinoma and renal cell carcinoma: A prospective multicenter study (2025)
-
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India (2025)
Collaboration Network
Top Collaborators
Lalit Kumar
DR. B.R.A. Institute Rotary Cancer Hospital (IN)
15 shared publications
- Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol
- Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial
- Multiple Myeloma: Impact of Time to Transplant on the Outcome
- Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
- Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women
Showing 5 of 15 shared publications
Deepali Jain
All India Institute of Medical Sciences (IN)
13 shared publications
- Assessment of Brain Metastasis at Diagnosis in Non–Small-Cell Lung Cancer: A Prospective Observational Study From North India
- EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management
- Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review
- Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
- A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
Showing 5 of 13 shared publications
Sachin Khurana
All India Institute of Medical Sciences (IN)
12 shared publications
- Assessment of Brain Metastasis at Diagnosis in Non–Small-Cell Lung Cancer: A Prospective Observational Study From North India
- Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial
- A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
- Early-Stage epithelial ovarian cancer: Predictors of survival
- An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of Pemetrexed-Carboplatin versus (Weekly) Paclitaxel-Carboplatin as First-Line Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
Showing 5 of 12 shared publications
Aruna Nambirajan
All India Institute of Medical Sciences (IN)
11 shared publications
- EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management
- Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review
- Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
- Mapping the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samples
- Retrospective application of WHO reporting system for lung cytopathology with assessment of risk of malignancy
Showing 5 of 11 shared publications
Anant Mohan
All India Institute of Medical Sciences (IN)
11 shared publications
- Lung Cancer in India
- Analysis of miR-375-3p, miR-197-3p, and miR-15a-5p Expression and Their Clinical Relevance as Biomarkers in Lung Cancer
- EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management
- Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
- Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing
Showing 5 of 11 shared publications
Deepam Pushpam
All India Institute of Medical Sciences (IN)
10 shared publications
- Assessment of Brain Metastasis at Diagnosis in Non–Small-Cell Lung Cancer: A Prospective Observational Study From North India
- A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
- Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model
- Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel
- Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles
Showing 5 of 10 shared publications
Sanjay Thulkar
Sanno University (JP)
7 shared publications
- EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management
- Multiple Myeloma: Impact of Time to Transplant on the Outcome
- Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcome
- Poems syndrome: consolidation with autologous stem cell transplantation
- Central nervous system metastasis from epithelial ovarian cancer- predictors of outcome
Showing 5 of 7 shared publications
Atul Sharma
All India Institute of Medical Sciences (IN)
7 shared publications
- Assessment of Brain Metastasis at Diagnosis in Non–Small-Cell Lung Cancer: A Prospective Observational Study From North India
- Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial
- Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial
- SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer
- Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from India
Showing 5 of 7 shared publications
Ranjit Kumar Sahoo
All India Institute of Medical Sciences (IN)
7 shared publications
- Multiple Myeloma: Impact of Time to Transplant on the Outcome
- Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
- Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcome
- Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial
- Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution
Showing 5 of 7 shared publications
Raja Pramanik
All India Institute of Medical Sciences (IN)
6 shared publications
- Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial
- Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
- Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model
- SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer
- Comprehensive Germline Genomic Profiling of Patients with Ovarian Cancer: A Cross-Sectional Study
Showing 5 of 6 shared publications
Sachin Kumar
All India Institute of Medical Sciences (IN)
6 shared publications
- Analysis of miR-375-3p, miR-197-3p, and miR-15a-5p Expression and Their Clinical Relevance as Biomarkers in Lung Cancer
- A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
- Rapid immunomagnetic co-capture assay for quantification of lung cancer associated exosomes
- RNA profile of immuno‐magnetically enriched lung cancer associated exosomes isolated from clinical samples
- Evaluation of the programmed death-ligand 1 mRNA expression and immunopositivity and their correlation with survival outcomes in Indian lung cancer patients
Showing 5 of 6 shared publications
Varsha Singh
All India Institute of Medical Sciences (IN)
5 shared publications
- EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management
- Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
- A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
- Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing
- P59.27 Complementary Utility of Combined ALK/ROS1 FISH with Immunohistochemistry for ALK/ROS1 Rearrangement Testing in Lung Cancer
Sushmita Pathy
5 shared publications
- Assessment of Brain Metastasis at Diagnosis in Non–Small-Cell Lung Cancer: A Prospective Observational Study From North India
- An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of Pemetrexed-Carboplatin versus (Weekly) Paclitaxel-Carboplatin as First-Line Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
- Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles
- Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB/IIIA Non-small Cell Lung Cancer – A Phase II trial
- Improving the performance status in advanced non-small cell lung cancer patients with chemotherapy (ImPACt trial): a phase 2 study
Sunil Kumar
All India Institute of Medical Sciences (IN)
5 shared publications
- Analysis of miR-375-3p, miR-197-3p, and miR-15a-5p Expression and Their Clinical Relevance as Biomarkers in Lung Cancer
- Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review
- Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing
- Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB/IIIA Non-small Cell Lung Cancer – A Phase II trial
- Evaluation of the programmed death-ligand 1 mRNA expression and immunopositivity and their correlation with survival outcomes in Indian lung cancer patients
Ishaan Gupta
Indian Institute of Technology Delhi (IN)
5 shared publications
- Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial
- Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India
- Integrating Artificial Intelligence-Driven Wearable Technology in Oncology Decision-Making: A Narrative Review
- Severity and mortality prediction models to triage Indian COVID-19 patients
- Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles
Similar Researchers
Based on overlapping research topics
Sajjad A. Bhatti
University of Arkansas for Medical Sciences
Lung Cancer Diagnosis and Treatment
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
A Al Kharabsheh
Harding University Main Campus
Lung Cancer Diagnosis and Treatment
Cancer-related molecular mechanisms research
Medical Case Studies
Μ. D. Willard
University of Arkansas for Medical Sciences
Lung Cancer Diagnosis and Treatment
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Matthew D. Thompson
University of Arkansas for Medical Sciences
Lung Cancer Diagnosis and Treatment
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Arafat Shabbir
University of Arkansas at Pine Bluff
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Medical Case Studies
Michael Gallagher
University of Central Arkansas
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Medical Case Studies